I was on the phone today with DEA spokesperson Russ Baer when the clock struck 5:00 pm on the East Coast without a final order from the agency making two chemicals from kratom Schedule I controlled substances. Baer said that the plan to place the plant alkaloids, mitragynine and 7-hydroxymitragynine, onto the most restrictive classification of drugs of abuse and public health risk is still in progress and "will come sooner rather than later."
The alkaloids have been known for over a decade to possess some modest opioid actions but their potential benefit for patients with chronic pain and substance dependence was overlooked in the notice of intent to place the botanical chemicals in the same class as heroin, LSD and mescaline.
The Donald Trump for President 2016 campaign has announced that it will pull out of the September 26 schedule debate between democratic presidential nominee Hillary Clinton and Republican nominee Trump, unless third-party candidates Gary Johnson and Jill Stein are also allowed to participate.
This is a tactical move believed by most analysis to help Trump because the third-party candidates seem to pull more from Clinton's support then they do from trumps.